Photobiomodulation
The science of light as medicine
Over 1,000 peer-reviewed studies support the therapeutic use of red and near-infrared light. Here is what the research actually shows.
The mechanism
How light becomes cellular energy
Photobiomodulation (PBM) is the application of red and near-infrared light to biological tissue. Unlike heat therapies or UV exposure, PBM works at the cellular level — photons are absorbed by specific chromophores within the mitochondria, triggering a cascade of biochemical responses.
The primary target is cytochrome c oxidase (CCO), the terminal enzyme in the mitochondrial electron transport chain. When CCO absorbs photons at the correct wavelengths, it dissociates nitric oxide — a molecule that inhibits cellular respiration — and restores normal ATP production.
The downstream effects are measurable and well-documented: increased ATP synthesis, reduced reactive oxygen species, upregulation of growth factors, and modulation of inflammatory cytokines. These are not placebo effects — they are reproducible biochemical events.
Wavelength specificity
Why 660nm and 850nm?
Not all wavelengths of light are therapeutic. The absorption spectrum of cytochrome c oxidase has distinct peaks — and Misogi devices are tuned precisely to those peaks for maximum cellular uptake.
| Wavelength | Type | Primary use |
|---|---|---|
| 630nm | Visible red | Skin collagen synthesis, wound healing, superficial tissue repair |
| 660nm | Deep red | Primary red wavelength — strongest CCO absorption, anti-inflammatory, muscle recovery |
| 810nm | Near-infrared | Neurological applications, deep muscle, joint and bone penetration |
| 850nm | Near-infrared | Primary NIR wavelength — deep muscle, joint, and connective tissue recovery |
| 940nm | Far near-infrared | Vascular effects, deep joint penetration, lymphatic support |
Clinical evidence
What the research shows
13 RCTs
on muscle recovery
Muscle recovery & performance
Multiple RCTs demonstrate that pre- and post-exercise PBM reduces DOMS, accelerates lactate clearance, and improves subsequent performance. A 2016 meta-analysis of 13 trials found significant reductions in muscle fatigue and soreness.
40%
average pain reduction
Joint pain & inflammation
Systematic reviews covering osteoarthritis, rheumatoid arthritis, and tendinopathy consistently show PBM reduces pain scores and inflammatory markers. NICE guidelines reference PBM for musculoskeletal conditions.
31%
increase in collagen density
Skin health & collagen
Red light at 630–660nm stimulates fibroblast proliferation and collagen type I synthesis. Clinical trials show measurable improvements in skin elasticity, wrinkle depth, and wound healing rates.
2.7×
improvement in sleep quality scores
Sleep & circadian rhythm
NIR light influences melatonin regulation and mitochondrial function in the pineal gland. Studies on athletes show improved sleep quality and duration following evening PBM sessions.
FDA cleared
for hair loss treatment
Hair & scalp health
PBM at 630–670nm is one of the few non-pharmaceutical interventions with FDA clearance for androgenetic alopecia. Multiple trials show increased hair count and density after 16–26 weeks of use.
50%
faster wound closure in trials
Wound healing & tissue repair
PBM accelerates wound closure by stimulating angiogenesis, fibroblast migration, and keratinocyte proliferation. Used clinically in post-surgical recovery and diabetic wound management.
Tissue depth
Surface to deep tissue
The depth of light penetration depends on wavelength. Misogi devices deliver both 660nm and 850nm simultaneously — red light addresses surface tissue while near-infrared reaches deep muscle, joint, and bone.
Safety profile
One of the safest therapeutic modalities
Photobiomodulation has an exceptional safety record across decades of clinical use. It is non-ionising, non-thermal at therapeutic doses, and has no documented systemic side effects in healthy adults.
Non-ionising radiation
Red and near-infrared light does not carry enough energy to ionise atoms or damage DNA — unlike UV, X-ray, or gamma radiation.
No thermal damage
At therapeutic irradiance levels, PBM does not heat tissue to damaging temperatures. The optional heat function in Misogi devices is a separate comfort feature.
IEC 62471 certified
All Misogi devices are tested and certified to IEC 62471 photobiological safety standards. Eye protection is included where required.
Contraindications
PBM is not recommended over active malignancies, during pregnancy, or directly over the thyroid. Consult a physician if you have photosensitive conditions or take photosensitising medications.
Important: PBM is not recommended over active malignancies, during pregnancy, or directly over the thyroid. Consult a physician if you have photosensitive conditions or take photosensitising medications.
Put the science to work
Every Misogi device is engineered to deliver therapeutic irradiance at the wavelengths the research supports — with a 90-day trial so you can verify the results yourself.
Shop the Range